Steve Aselage, Director at Travere Therapeutics, Inc. (TVTX), sold 25,000 shares at $30.75 ($769K) on 2021-02-02, disclosed to the SEC on 2021-02-02.
Open-market sale of $769k TVTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TVTX | SELL | 2022-05-12 | $113K | — | Filing → |
| ACER | BUY | 2021-12-13 | $21K | — | Filing → |
| TVTX | SELL | 2021-11-18 | $935K | — | Filing → |